Royalty Pharma Plc Stock Price on September 30, 2023
| RPRX Stock | USD 39.73 0.14 0.35% |
If you're considering investing in Royalty Stock, it is important to understand the factors that can impact its price. As of today, the current price of Royalty Pharma stands at 39.73, as last reported on the 13th of November 2025, with the highest price reaching 40.01 and the lowest price hitting 39.38 during the day. At this stage we consider Royalty Stock to be very steady. Royalty Pharma Plc maintains Sharpe Ratio (i.e., Efficiency) of 0.0918, which implies the firm had a 0.0918 % return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Royalty Pharma Plc, which you can use to evaluate the volatility of the company. Please check Royalty Pharma's Semi Deviation of 1.54, coefficient of variation of 1009.18, and Risk Adjusted Performance of 0.067 to confirm if the risk estimate we provide is consistent with the expected return of 0.15%. At this time, Royalty Pharma's Total Stockholder Equity is fairly stable compared to the past year. Stock Based Compensation is likely to rise to about 2.4 M in 2025, whereas Common Stock Shares Outstanding is likely to drop slightly above 440.6 M in 2025. . Price To Sales Ratio is likely to drop to 4.77 in 2025. Price Earnings Ratio is likely to drop to 12.58 in 2025. Royalty Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Price Book 2.5951 | Enterprise Value Ebitda 15.0051 | Price Sales 9.7253 | Shares Float 374.6 M | Dividend Share 0.87 |
Royalty Pharma Main Headline on 26th of October 2023
Acquisition by Riggs Rory B of 7747 shares of Royalty Pharma... by Riggs Rory B
Filed transaction by Royalty Pharma Plc director. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Royalty Pharma Valuation on September 30, 2023
It is possible to determine the worth of Royalty Pharma on a given historical date. On September 30, 2023 Royalty was worth 25.67 at the beginning of the trading date compared to the closed value of 25.73. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Royalty Pharma stock. Still, in general, we apply an absolute valuation method to find Royalty Pharma's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Royalty Pharma where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Royalty Pharma's related companies.
| Open | High | Low | Close | Volume | |
10/26/2023 | 25.67 | 25.96 | 25.66 | 25.73 | 1,731,114 |
| 25.79 | 25.79 | 24.72 | 24.75 | 2,505,886 |
| Backtest Royalty Pharma | | | Royalty Pharma History | | | Royalty Pharma Valuation | Next |
Royalty Pharma Trading Date Momentum on September 30, 2023
The event impact on price volatility cannot be determined at this time. Please check this event after some time to allow current data to be analyzed.Royalty Pharma Plc Fundamentals Correlations and Trends
By evaluating Royalty Pharma's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Royalty Pharma's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Royalty financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Royalty Pharma Stock history
Royalty Pharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Royalty is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Royalty Pharma Plc will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Royalty Pharma stock prices may prove useful in developing a viable investing in Royalty Pharma
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 594 M | 440.6 M | |
| Net Income Applicable To Common Shares | 49.3 M | 46.8 M |
Royalty Pharma Quarterly Net Working Capital |
|
Royalty Pharma Stock Technical Analysis
Royalty Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Royalty Pharma Period Price Range
Low | November 13, 2025
| High |
0.00 | 0.00 |
Royalty Pharma Plc cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Royalty Pharma November 13, 2025 Market Strength
Market strength indicators help investors to evaluate how Royalty Pharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Royalty Pharma shares will generate the highest return on investment. By undertsting and applying Royalty Pharma stock market strength indicators, traders can identify Royalty Pharma Plc entry and exit signals to maximize returns
Royalty Pharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Royalty Pharma's price direction in advance. Along with the technical and fundamental analysis of Royalty Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Royalty to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.067 | |||
| Jensen Alpha | 0.0937 | |||
| Total Risk Alpha | (0.16) | |||
| Sortino Ratio | 0.0209 | |||
| Treynor Ratio | 0.2984 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Royalty Stock Analysis
When running Royalty Pharma's price analysis, check to measure Royalty Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Royalty Pharma is operating at the current time. Most of Royalty Pharma's value examination focuses on studying past and present price action to predict the probability of Royalty Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Royalty Pharma's price. Additionally, you may evaluate how the addition of Royalty Pharma to your portfolios can decrease your overall portfolio volatility.